Lung Cancer Mortality Risk Predicted by Blood Test
A blood-based test developed by researchers can predict the risk of dying from lung cancer when combined with a personalized risk model.
Read MorePosted by Chris Wolski | Jun 30, 2023 | Lung Cancer |
A blood-based test developed by researchers can predict the risk of dying from lung cancer when combined with a personalized risk model.
Read MorePosted by Melanie Hamilton-Basich | Jun 23, 2023 | Lung Cancer |
Owlstone Medical announced new data on the development of a breath biopsy screening test for the early detection of lung cancer.
Read MorePosted by Melanie Hamilton-Basich | May 30, 2023 | Lung Cancer |
The first-generation lung cancer classification model based on gene expression data is already available for use within Qlucore Insights.
Read MorePosted by Chris Wolski | Apr 18, 2023 | Lung Cancer |
New data demonstrates Exai Bio’s novel RNA- and AI-based platform detected non-small cell lung cancer with high accuracy.
Read MorePosted by Andy Lundin | Feb 27, 2023 | Lung Cancer |
The Q-submission phase is a regulatory step which allows regular and in-depth discussions with the FDA on key topics.
Read More